MILKA MEJIA: Open Payments
NPI 1407201189 · UNION CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,360 in 32 payments from 8 companies in 2025. Trend: 2023 $853 · 2024 $1,822 · 2025 $1,360
Food & beverage: $1,344Education: $16
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $571 |
| GlaxoSmithKline, LLC. | 4 | $251 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $238 |
| Exact Sciences Corporation | 5 | $132 |
| Gilead Sciences, Inc. | 1 | $102 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| Novo Nordisk Inc | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
Products named: AIRSUPRA, JARDIANCE, SHINGRIX, AREXVY, FASENRA, Epclusa, Cologuard Collection Kit, The Cologuard Plus Collection Kit.
Industry payments across NJ — which companies pay providers there.
